These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 10819234)

  • 1. Enhanced escape of non-esterified fatty acids from tissue uptake: its role in impaired insulin-induced lowering of total rate of appearance in obesity and Type II diabetes mellitus.
    Riemens SC; Sluiter WJ; Dullaart RP
    Diabetologia; 2000 Apr; 43(4):416-26. PubMed ID: 10819234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body fat distribution, insulin mediated suppression of non-esterified fatty acids and plasma triglycerides in obese subjects.
    Herranz L; Zapata A; Grande C; Megia A; Pallardo LF
    Horm Metab Res; 1998 Mar; 30(3):141-5. PubMed ID: 9566856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease.
    Meyer MM; Levin K; Grimmsmann T; Beck-Nielsen H; Klein HH
    Diabetologia; 2002 Jun; 45(6):813-22. PubMed ID: 12107725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp.
    Golay A; Defronzo RA; Thorin D; Jequier E; Felber JP
    Diabete Metab; 1988; 14(4):443-51. PubMed ID: 3066652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma phospholipid transfer protein activity is related to insulin resistance: impaired acute lowering by insulin in obese Type II diabetic patients.
    Riemens SC; van Tol A; Sluiter WJ; Dullaart RP
    Diabetologia; 1998 Aug; 41(8):929-34. PubMed ID: 9726595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of glimepiride and metformin on free fatty acid in patients with Type 2 diabetes mellitus].
    Tang JZ; Mao JP; Yang ZF; Zhou ZG; Tang WL; Feng Q
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):631-4. PubMed ID: 16114544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor alpha -238G>A genotype alters postprandial plasma levels of free fatty acids in obese individuals with type 2 diabetes mellitus.
    Fontaine-Bisson B; Wolever TM; Chiasson JL; Rabasa-Lhoret R; Maheux P; Josse RG; Leiter LA; Rodger NW; Ryan EA; El-Sohemy A
    Metabolism; 2007 May; 56(5):649-55. PubMed ID: 17445540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of masoprocol on carbohydrate and lipid metabolism in a rat model of Type II diabetes.
    Reed MJ; Meszaros K; Entes LJ; Claypool MD; Pinkett JG; Brignetti D; Luo J; Khandwala A; Reaven GM
    Diabetologia; 1999 Jan; 42(1):102-6. PubMed ID: 10027587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of metformin on glucose, insulin and lipid metabolism in patients with mild hypertriglyceridaemia and non-insulin dependent diabetes by glucose tolerance test criteria.
    Hollenbeck CB; Johnston P; Varasteh BB; Chen YD; Reaven GM
    Diabete Metab; 1991; 17(5):483-9. PubMed ID: 1752350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.
    Basu R; Shah P; Basu A; Norby B; Dicke B; Chandramouli V; Cohen O; Landau BR; Rizza RA
    Diabetes; 2008 Jan; 57(1):24-31. PubMed ID: 17914032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
    Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
    Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversibility of insulin resistance in obese diabetic patients: role of plasma lipids.
    Mingrone G; DeGaetano A; Greco AV; Capristo E; Benedetti G; Castagneto M; Gasbarrini G
    Diabetologia; 1997 May; 40(5):599-605. PubMed ID: 9165230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
    Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of metformin treatment on erythrocyte insulin binding in normal weight subjects, in obese non diabetic subjects, in type 1 and type 2 diabetic patients.
    Rizkalla SW; Elgrably F; Tchobroutsky G; Slama G
    Diabete Metab; 1986 Aug; 12(4):219-24. PubMed ID: 3533670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mismatch between insulin-mediated glucose uptake and blood flow in the heart of patients with Type II diabetes.
    Iozzo P; Chareonthaitawee P; Rimoldi O; Betteridge DJ; Camici PG; Ferrannini E
    Diabetologia; 2002 Oct; 45(10):1404-9. PubMed ID: 12378381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulfonylurea therapy fails to diminish insulin resistance in type I-diabetic subjects.
    Keller U; Müller R; Berger W
    Horm Metab Res; 1986 Sep; 18(9):599-603. PubMed ID: 2946637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two days of a very low calorie diet reduces endogenous glucose production in obese type 2 diabetic patients despite the withdrawal of blood glucose-lowering therapies including insulin.
    Jazet IM; Pijl H; Frölich M; Romijn JA; Meinders AE
    Metabolism; 2005 Jun; 54(6):705-12. PubMed ID: 15931603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fasting-based estimates of insulin sensitivity in overweight and obesity: a critical appraisal.
    Ruige JB; Mertens IL; Bartholomeeusen E; Dirinck E; Ferrannini E; Van Gaal LF
    Obesity (Silver Spring); 2006 Jul; 14(7):1250-6. PubMed ID: 16899806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of free fatty acid kinetics during non-equilibrium tracer conditions in man: implications for the estimation of the rate of appearance of free fatty acids.
    Riemens SC; Dullaart RP; Franssen EJ; Piers DA; Reitsma WD; Sluiter WJ
    Eur J Clin Invest; 1998 Feb; 28(2):108-14. PubMed ID: 9541124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Energy expenditure in non-insulin dependent diabetic subjects on metformin or sulphonylurea therapy.
    Leslie P; Jung RT; Isles TE; Baty J
    Clin Sci (Lond); 1987 Jul; 73(1):41-5. PubMed ID: 3301165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.